Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: TNS007
MIFTS: 39

Taeniasis

Categories: Infectious diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Taeniasis

About this section

MalaCards integrated aliases for Taeniasis:

Name: Taeniasis 12 76 15
Infection by Taeniarhynchus Saginatus 12
Taenia Saginata Infectious Disease 12
Taenia Saginata Infection 73
Beef Tapeworm Infection 12

Classifications:

MalaCards categories:
Global: Infectious diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:0050596
ICD10 33 B68.1 B68 B68.9
ICD9CM 35 123.2
SNOMED-CT 68 69163003
UMLS 73 C0152073
Sources

Summaries for Taeniasis

About this section
Disease Ontology : 12 A parasitic helminthiasis infectious disease that has material basis in Taenia solium or has material basis in Taenia saginata, which are transmitted by ingestion of undercooked contaminated meat.

MalaCards based summary : Taeniasis, also known as infection by taeniarhynchus saginatus, is related to cysticercosis and ancylostomiasis. An important gene associated with Taeniasis is MT-CO1 (Mitochondrially Encoded Cytochrome C Oxidase I), and among its related pathways/superpathways is Primary immunodeficiency. The drugs Albendazole and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and colon.

Wikipedia : 76 Taeniasis is a parasitic disease due to infection with tapeworms belonging to the genus Taenia. The two... more...

Sources

Related Diseases for Taeniasis

About this section

Diseases related to Taeniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 142)
# Related Disease Score Top Affiliating Genes
1 cysticercosis 33.7 MT-CO1 MT-ND1 TACSTD2
2 ancylostomiasis 31.1 CD40LG MT-CO1
3 hymenolepiasis 30.5 CD79A MT-CO1
4 echinococcosis 30.4 CD40LG CD79A MT-CO1 MT-ND1
5 clonorchiasis 30.3 CD79A CTSL
6 sparganosis 10.8 CTSL MT-CO1
7 deafness, nonsyndromic sensorineural, mitochondrial 10.8 MT-CO1 MT-ND1
8 myasthenic syndrome, congenital, 10 10.8 CD40LG MT-CO1
9 leber optic atrophy 10.8 MT-CO1 MT-ND1
10 fasciolopsiasis 10.8 CD40LG CTSL
11 gnathomiasis 10.7 CTSL MT-CO1
12 fascioliasis 10.7 CTSL MT-CO1
13 coenurosis 10.6 MT-CO1 MT-ND1 TACSTD2
14 selective igg deficiency disease 10.6 CD40LG CD79A
15 c1q nephropathy 10.6 CD40LG CD79A
16 meningovascular neurosyphilis 10.6 CD40LG CD79A
17 alpha chain disease 10.6 CD40LG CD79A
18 brill-zinsser disease 10.6 CD40LG CD79A
19 exudative glomerulonephritis 10.6 CD40LG CD79A
20 cork-handlers' disease 10.6 CD40LG CD79A
21 salpingo-oophoritis 10.6 CD40LG CD79A
22 early yaws 10.6 CD40LG CD79A
23 ventilation pneumonitis 10.6 CD40LG CD79A
24 chronic interstitial cystitis 10.6 CD40LG CD79A
25 axillary adenitis 10.6 CD40LG CD79A
26 cryofibrinogenemia 10.6 CD40LG CD79A
27 trichostrongyloidiasis 10.6 CD40LG CD79A
28 subacute bacterial endocarditis 10.6 CD40LG CD79A
29 cystic echinococcosis 10.6 CD40LG MT-CO1 MT-ND1
30 heterophyiasis 10.6 CD40LG CD79A
31 immunoglobulin g deficiency 10.6 CD40LG CD79A
32 orbital granuloma 10.6 CD40LG CD79A
33 transient hypogammaglobulinemia of infancy 10.6 CD40LG CD79A
34 hyperglobulinemic purpura 10.6 CD40LG CD79A
35 gastroduodenitis 10.6 CD40LG CD79A
36 bacterial conjunctivitis 10.6 CD40LG CD79A
37 heavy chain disease 10.6 CD40LG CD79A
38 ophthalmia neonatorum 10.6 CD40LG CD79A
39 immunoglobulin a deficiency 1 10.6 CD40LG CD79A
40 parotid disease 10.6 CD40LG CD79A
41 cerebral arteritis 10.6 CD40LG CD79A
42 selective immunoglobulin deficiency disease 10.6 CD40LG CD79A
43 geniculate herpes zoster 10.6 CD40LG CD79A
44 erythema elevatum diutinum 10.6 CD40LG CD79A
45 sporotrichosis 10.6 CD40LG CD79A
46 fallopian tube disease 10.6 CD40LG CD79A
47 hyperimmunoglobulin syndrome 10.6 CD40LG CD79A
48 congenital syphilis 10.6 CD40LG CD79A
49 polyclonal hypergammaglobulinemia 10.6 CD40LG CD79A
50 monoclonal paraproteinemia 10.6 CD40LG CD79A

Graphical network of the top 20 diseases related to Taeniasis:



Diseases related to Taeniasis
Sources

Symptoms & Phenotypes for Taeniasis

About this section
Sources

Drugs & Therapeutics for Taeniasis

About this section

Drugs for Taeniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 39)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Albendazole Approved, Vet_approved Phase 3,Phase 2,Not Applicable 54965-21-8 2082
2
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 50-02-2 5743
3
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
4
Praziquantel Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 3,Not Applicable 55268-74-1 4891
5
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
6
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
7 tannic acid Approved, Nutraceutical Phase 3
8 Anthelmintics Phase 3,Phase 2,Phase 1,Not Applicable
9 Anti-Infective Agents Phase 3,Phase 2,Phase 1,Not Applicable
10 Antimitotic Agents Phase 3,Phase 2,Not Applicable
11 Antiparasitic Agents Phase 3,Phase 2,Phase 1,Not Applicable
12 Antiprotozoal Agents Phase 3,Phase 2,Not Applicable
13 Antacids Phase 3
14 Antiemetics Phase 3,Phase 2,Not Applicable
15 Anti-Inflammatory Agents Phase 3,Phase 2,Not Applicable
16 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Not Applicable
17 Anti-Ulcer Agents Phase 3
18 Autonomic Agents Phase 3,Phase 2,Not Applicable
19 BB 1101 Phase 3,Phase 2,Not Applicable
20 Dexamethasone acetate Phase 3,Phase 2,Not Applicable 1177-87-3
21 Gastrointestinal Agents Phase 3,Phase 2,Not Applicable
22 glucocorticoids Phase 3,Phase 2,Not Applicable
23 HIV Protease Inhibitors Phase 3,Phase 2
24 Hormone Antagonists Phase 3,Phase 2,Not Applicable
25 Hormones Phase 3,Phase 2,Not Applicable
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Not Applicable
27 Peripheral Nervous System Agents Phase 3,Phase 2,Not Applicable
28
protease inhibitors Phase 3,Phase 2
29 Proton Pump Inhibitors Phase 3
30 Anticonvulsants Phase 2, Phase 3,Not Applicable
31 Carbonic Anhydrase Inhibitors Phase 2, Phase 3
32 diuretics Phase 2, Phase 3
33 Natriuretic Agents Phase 2, Phase 3
34 Benzimidazole Experimental, Investigational Phase 1 51-17-2
35
Oxfendazole Investigational, Vet_approved Phase 1 53716-50-0 40854
36
Phenytoin Approved, Vet_approved Not Applicable 57-41-0 1775
37
Niclosamide Approved, Investigational, Vet_approved Not Applicable 50-65-7 4477
38 Diuretics, Potassium Sparing Not Applicable
39 Sodium Channel Blockers Not Applicable

Interventional clinical trials:

(show all 21)
# Name Status NCT ID Phase Drugs
1 Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Completed NCT02243644 Phase 3 7 days of albendazole 15 mg/kg/day;28 days of albendazole 15 mg/kg/day
2 A Pilot Study of Neurocysticercosis Treatment Completed NCT00283699 Phase 3 albendazole
3 Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients Completed NCT00290823 Phase 3 Albendazole;Dexamethasone;Omeprazole
4 Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) Completed NCT00441285 Phase 2, Phase 3 Praziquantel;Albendazole;ABZ Placebo;PZQ Placebo
5 Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) Recruiting NCT02947581 Phase 3 Albendazole and praziquantel;Albendazole and praziquantel placebo
6 Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) Recruiting NCT02945527 Phase 2, Phase 3 Acetazolamide;Dexamethasone
7 RCT ALB for SA Cysticercosis Withdrawn NCT00133458 Phase 3 Albendazole
8 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Completed NCT00527579 Phase 1 [F-18]FBR
9 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Completed NCT00526916 Phase 1 [C-11]PBR28
10 Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole Completed NCT02234570 Phase 1 Oxfendazole
11 Single Ascending Dose Safety Study of Oxfendazole Withdrawn NCT01584362 Phase 1 oxfendazole;placebo;oxfendazole;oxfendazole;oxfendazole;oxfendazole;oxfendazole
12 EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso Completed NCT03095339 Not Applicable
13 Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis Completed NCT00001912
14 Taenia Solium Control Case Study in Zambia Completed NCT01368354 Not Applicable
15 Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis Completed NCT00004403 Not Applicable albendazole;dexamethasone;phenytoin
16 Targeted Screening for Taenia Solium Tapeworms Completed NCT01296958 Not Applicable Niclosamide
17 Treatment of Patients With Cysticercosis With Praziquantel or Albendazole Recruiting NCT00001205
18 Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa? Recruiting NCT02612896 Not Applicable Mass drug administration, praziquantel 10mg/kg
19 Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian Province in Poland Recruiting NCT03490435
20 People Presenting With Neurocysticercosis in North America Terminated NCT02233855
21 Mass Treatment T Solium Community Study Terminated NCT00138359 Not Applicable Niclosamide

Search NIH Clinical Center for Taeniasis

Sources

Genetic Tests for Taeniasis

About this section
Sources

Anatomical Context for Taeniasis

About this section

MalaCards organs/tissues related to Taeniasis:

41
Brain, Testes, Colon
Sources

Publications for Taeniasis

About this section

Articles related to Taeniasis:

(show top 50) (show all 231)
# Title Authors Year
1
HDP2: a ribosomal DNA (NTS-ETS) sequence as a target for species-specific molecular diagnosis of intestinal taeniasis in humans. ( 29486767 )
2018
2
On the Visual Diagnosis of Human Taeniasis by Capsule Endoscopy. ( 29914643 )
2018
3
Notes and recommendations for the establishment of control programs for taeniasis and cysticercosis due to Taenia solium in PeruNotes and recommendations for the establishment of control programs for Taeniasis/cysticercosis in Peru. ( 29924259 )
2018
4
Prevalence of Echinococcus granulosus Taeniasis in Stray Dogs in the Region of Constantine (North-East Algeria). ( 28929396 )
2017
5
Target product profiles for the diagnosis of Taenia solium taeniasis, neurocysticercosis and porcine cysticercosis. ( 28892472 )
2017
6
Mapping the residual incidence of taeniasis and cysticercosis in Colombia, 2009-2013, using geographical information systems: Implications for public health and travel medicine. ( 29288739 )
2017
7
Taeniasis in a Spanish girl. ( 27601094 )
2017
8
Development of a health education intervention strategy using an implementation research method to control taeniasis and cysticercosis in Burkina Faso. ( 28569208 )
2017
9
Human taeniasis: current insights into prevention and management strategies in endemic countries. ( 28615981 )
2017
10
Taeniasis: An Unusual Presentation. ( 28764162 )
2017
11
A systematic review of taeniasis, cysticercosis and trichinellosis in Vietnam. ( 28320455 )
2017
12
Taeniasis caused by Taenia saginata in Gianyar town and Taenia solium in Karangasem villages of Bali, Indonesia, 2011-2016: How to detect tapeworm carriers, anamnesis or microscopy? ( 28634145 )
2017
13
Taeniasis: A possible cause of ileal bleeding. ( 29291202 )
2017
14
Survey of Obstetrician-Gynecologists in the United States About Taeniasis and Cysticercosis. ( 28077749 )
2017
15
Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group. ( 28449318 )
2017
16
Geospatial and age-related patterns of Taenia solium taeniasis in the rural health zone of Kimpese, Democratic Republic of Congo. ( 26996821 )
2016
17
Cysticercosis/taeniasis endemicity in Southeast Asia: Current status and control measures. ( 26802488 )
2016
18
GPS Tracking of Free-Ranging Pigs to Evaluate Ring Strategies for the Control of Cysticercosis/Taeniasis in Peru. ( 27035825 )
2016
19
Endoscopy as a diagnostic and therapeutic alternative technique of taeniasis. ( 26219408 )
2016
20
About human taeniasis and Taenia saginata diagnosis by endoscopy. ( 26984440 )
2016
21
Control of Taenia solium taeniasis/cysticercosis: The best way forward for sub-Saharan Africa? ( 27140860 )
2016
22
Taeniasis vs cysticercosis infection routes. ( 27262080 )
2016
23
Behavioral and hormonal changes associated with the infective dose in experimental taeniasis in golden hamsters (Mesocricetus auratus). ( 27109310 )
2016
24
AuthorA's answer: About human taeniasis and Taenia saginata diagnosis by endoscopy. ( 27650793 )
2016
25
Pathogenesis of Taenia solium taeniasis and cysticercosis. ( 26824681 )
2016
26
Taeniasis in non-descript dogs in Ngorongoro, Tanzania: Prevalence and predisposing factors. ( 27247069 )
2016
27
Taenia solium Taeniasis and Cysticercosis in Southeast Asia. ( 26834197 )
2016
28
Taeniasis among Refugees Living on Thailand-Myanmar Border, 2012. ( 26401787 )
2015
29
Seroprevalence and risk factors of human cysticercosis and taeniasis prevalence in a highly endemic area of epilepsy in Bangoua, west Cameroon. ( 26747010 )
2015
30
A school based cluster randomised health education intervention trial for improving knowledge and attitudes related to Taenia solium cysticercosis and taeniasis in Mbulu district, northern Tanzania. ( 25719902 )
2015
31
On Taeniasis/Cysticercosis Mimicking Lymphoma on PET/CT Imaging. ( 25899585 )
2015
32
On taeniasis, hydatidosis and 'figatellu'. ( 24813526 )
2014
33
Recent situation of taeniasis in Mongolia (2002-2012). ( 24850968 )
2014
34
Immunology of Taenia solium taeniasis and human cysticercosis. ( 24962350 )
2014
35
Taenia solium taeniasis and cysticercosis control and elimination through community-based interventions. ( 25544938 )
2014
36
Prevalence and risk factors for Taenia solium taeniasis in Kaniyambadi block, Tamil Nadu, South India. ( 25116828 )
2014
37
Current status of taeniasis and cysticercosis in Vietnam. ( 24850954 )
2014
38
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. ( 23922733 )
2013
39
Advances in diagnosis and spatial analysis of cysticercosis and taeniasis. ( 23985371 )
2013
40
Correction: Epidemiology and Management of Cysticercosis and Taenia solium Taeniasis in Europe, Systematic Review 1990-2011. ( 24367473 )
2013
41
Rare case of disseminated cysticercosis and taeniasis in a Japanese traveler after returning from India. ( 23629930 )
2013
42
Human taeniasis in the Republic of Korea: hidden or gone? ( 23467688 )
2013
43
Mini review on chemotherapy of taeniasis and cysticercosis due to Taenia solium in Asia, and a case report with 20 tapeworms in China. ( 23959481 )
2013
44
Bayesian modelling to estimate the test characteristics of coprology, coproantigen ELISA and a novel real-time PCR for the diagnosis of taeniasis. ( 23464616 )
2013
45
Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. ( 23947762 )
2013
46
Current status of taeniasis in Thailand. ( 23467328 )
2013
47
A case of taeniasis diagnosed postpartum. ( 23707843 )
2013
48
Current status of human taeniasis in Lao People's Democratic Republic. ( 23710098 )
2013
49
Current status and perspectives of cysticercosis and taeniasis in Japan. ( 23467264 )
2013
50
Therapeutic effect of praziquantel against Taeniasis asiatica. ( 23618773 )
2013
Sources

Variations for Taeniasis

About this section
Sources

Expression for Taeniasis

About this section
Search GEO for disease gene expression data for Taeniasis.
Sources

Pathways for Taeniasis

About this section

Pathways related to Taeniasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Primary immunodeficiency 37
10.19 CD40LG CD79A
Sources

GO Terms for Taeniasis

About this section

Cellular components related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of membrane GO:0016021 9.32 CD40LG CD79A MT-CO1 MT-ND1 PIGS RTP1

Biological processes related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 B cell proliferation GO:0042100 8.62 CD40LG CD79A
Sources

Sources for Taeniasis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....